General Information
Lilly DM2 GPGF
A Phase 2, Double-Blind, Placebo-Controlled, 3-Month Trial of LY3298176 versus Placebo in Patients with Type 2 Diabetes Mellitus.
| Protocol | I8F-MC-GPGF |
|---|---|
| Identifier | PO # 4900608127 |
| UID | 2bec2a7e-85e1-4088-9b0a-1de9539d3ab6 |
| Status | Done - Archived |
| Phase | 2 |
| Category | Diabetes Type 2 / Adult |
| Launch Year | 2017 |
| NCT Number | - |
| Created | 2017-08-07 12:03 |
| Last Updated | 2017-08-07 12:03 |
Description
No description provided.
Comment
PCRS
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | 2017-12-20 | No |
| Enrollment Open | 2017-10-21 | No |
| First Patient First Visit | No | |
| Site Initiation Mtg. | 2017-10-13 | No |
| PI Meeting Start | No | |
| PI Meeting End | No | |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | 2018-06-27 | No |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Martinez, Gilbert | GJMartinez | No |
| Recruiter | - | No | |
| Coordinator | Valenzuela, Louisito | LValenzuela | No |
| Regulatory | Ramirez, Claudia | CRamirez | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | Eli Lilly and Company |
|---|---|
| Division | Lilly |
| Team | Lilly |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | |
|---|---|
| CRO | Inventiv Health Clinical, LLC |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Gainsboro |
| Currency | - |
